Charles River Laboratories International, Inc.

NYSE:CRL

Market Cap

USD 7.36 B

Share Price

USD 149.79

Avg Daily Volume

1,537,950

Change (1 day)

-3.04%

Change (1 year)

-31.36%

Change (YTD)

-18.86%

Charles River Laboratories International, Inc. EBT Margin for the Trailing 12 Months (TTM) ending March 29, 2025: 0.75%

Charles River Laboratories International, Inc. EBT Margin is 0.75% for the Trailing 12 Months (TTM) ending March 29, 2025, a -94.40% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.
  • Charles River Laboratories International, Inc. EBT Margin for the Trailing 12 Months (TTM) ending March 30, 2024 was 13.36%, a -15.02% change year over year.
  • Charles River Laboratories International, Inc. EBT Margin for the Trailing 12 Months (TTM) ending April 01, 2023 was 15.72%, a 8.63% change year over year.
  • Charles River Laboratories International, Inc. EBT Margin for the Trailing 12 Months (TTM) ending March 26, 2022 was 14.47%, a -3.89% change year over year.
  • Charles River Laboratories International, Inc. EBT Margin for the Trailing 12 Months (TTM) ending March 27, 2021 was 15.06%, a 39.85% change year over year.
Key Data
Date EBT Margin Operating Income Margin Gross Profit Margin EBIT Margin